Sphere Fluidics awarded gold accreditation by investors in people

FHS
June 14, 2024
10:47 am

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced that it has received the ‘We invest in people’ Gold accreditation, a prestigious award presented by Investors in People (IIP). This accolade is in recognition of the Company’s commitment to excellence in people management and continuous improvement in workplace practices.

Heidelberg Pharma announces financial figures and reports on successful business performance in 2023 – Biotech Investments

EQS-News: Heidelberg Pharma AG / Key word(s): Annual Results Heidelberg Pharma announces financial figures and reports on successful business performance in 2023 25.03.2024 / 07:10

March 26, 2024

FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma

Two CAR T-cell therapies for multiple myeloma won favorable recommendations for earlier use in the disease during a day-long meeting of the FDA Oncologic Drugs

March 17, 2024

Stelara Biosimilar OK’d With Interchangeability

A biosimilar version of the multipurpose biologic drug ustekinumab has been approved by the FDA and can be swapped interchangeably with the original product sold

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.